Lifetime Comorbidity of DSM-IV Mood and Anxiety Disorders and Specific Drug Use Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To present nationally representative data on the lifetime prevalence and comorbidity of 8 specific drug use disorders, separately for abuse and dependence, and mood and anxiety disorders. METHOD: Data come from a representative sample (N=43,093) of the United States civilian, noninstitutional population 18 years and older. Diagnoses of mood, anxiety, and drug use disorders were based upon face-to-face personal interviews using the Alcohol Use Disorder and Associated Disabilities Interview Schedule-DSM-IV Version (AUDADIS-IV). RESULTS: Associations between specific mood and anxiety disorders and specific drug use disorders were virtually all positive and statistically significant (p<.05). In general, associations were greater for dependence than abuse, greater for mood than anxiety disorders, and in some instances stronger among women than men (p<.05). Large odds ratios also were observed for individuals with comorbid mood and anxiety disorders. CONCLUSION: The comorbidity between specific mood and anxiety disorders and specific drug use disorders is pervasive in the U.S. population. Findings suggest that comorbid psychiatric disorders may increase the risk of greater involvement in more serious illicit drug use disorders and that the greater comorbidity between mood and anxiety and drug use disorders among women may reflect greater deviance and psychopathology among drug-using women than men. Findings also suggest that drug abuse prevention and intervention efforts should address other psychiatric conditions. Further, definitions of drug use disorder phenotypes should give careful consideration to other psychiatric conditions as meaningful characteristics of case heterogeneity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Anxiety disorders are highly comorbid with substance use disorders [43]”
From Correlates of Quality of Life in Anxiety Disorders: Review of Recent Research (2021) · cites this paper as [43]
In the citing paper
“relapse for SUD, experience increased distress, internalized stigma, lower quality of life, and a higher likelihood of using multiple substances than people diagnosed with SUD alone(Carpentier et al., 2009; Chang et al., 2019; Conway et al., 2006; Lejuez et al., 2008; Rogers et al., 2019).”
From A systematic review and meta-analysis of psychosocial interventions for persons with comorbid anxiety and substance use disorders (2024) · cites this paper as Conway et al., 2006
In the citing paper
“GAD, PD, agoraphobia, social phobia, and specific phobias are often found to be highly co-morbid with each other as well as other psychiatric disorders including depression, PTSD, and substance-use disorders (Conway et al, 2006;Kaufman and Charney, 2000;Regier et al, 1998).”
From Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond (2017) · cites this paper as Conway et al, 2006
In the citing paper
“Furthermore, gambling disorder frequently co-occurs with substance use disorders, particularly alcohol and nicotine, as well as mood and anxiety disorders (Conway, Compton, Stinson, & Grant, 2006; B. F. Grant et al., 2004b; Petry et al., 2005; Ronzitti, Kraus, Hoff, & Potenza, 2018).”
From Cued for Risk: Evidence for an Incentive Sensitization Framework to Explain the Interplay between Stress and Anxiety, Substance Abuse, and Reward Uncertainty in Disordered Gambling Behavior (2019) · cites this paper as Conway, Compton, Stinson, & Grant, 2006
Citations
Cites
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.593 · Cited by 20,391
Regier, D. A. (1990) · JAMA · doi:10.1001/jama.1990.03450190043026 · Cited by 3,962
Smoking and Mental Illness: A Population-Based Prevalence Study
Lasser, K., Boyd, J. W., Woolhandler, S., Himmelstein, D. U., McCormick, D., & Bor, D. H. (2000) · JAMA · doi:10.1001/jama.284.20.2606 · Cited by 2,508
Kessler, R. C. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830160031005 · Cited by 2,085
Kessler, R. C., Nelson, C. B., McGonagle, K. A., Edlund, M. J., Frank, R. G., & Leaf, P. J. (1996) · American Journal of Orthopsychiatry · doi:10.1037/h0080151 · Cited by 1,378
Grant, B. F., Dawson, D. A., Stinson, F. S., Chou, P. S., Kay, W., & Pickering, R. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00070-x · Cited by 1,110
Self-citationHelzer, J. E., & Pryzbeck, T. R. (1988) · Journal of Studies on Alcohol · doi:10.15288/jsa.1988.49.219 · Cited by 1,081
Comorbidity of substance use disorders with mood and anxiety disorders
Merikangas, K. R., Mehta, R. L., Molnar, B. E., Walters, E. E., Swendsen, J. D., Aguilar-Gaziola, S., Bijl, R., Borges, G., Caraveo-Anduaga, J. J., Dewit, D. J., et al. (1998) · Addictive Behaviors · doi:10.1016/s0306-4603(98)00076-8 · Cited by 725
Grant, B. (1995) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(95)01134-k · Cited by 686
Self-citationGrant, B. F., Stinson, F. S., Dawson, D. A., Chou, S. P., Ruan, W. J., & Pickering, R. P. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.4.361 · Cited by 644
Self-citation
Cited by
Items 801–900 of 933
Committing to Psychiatric Ethics
Roberts, L. W. (2011) · AJOB Primary Research · doi:10.1080/21507716.2011.630058
“Co-occurring conditions, such as substance dependence, intellectual disability, and medically complex diseases, are becoming usual rather than rare (Conway et al. 2006; Regier et al. 1990; U.S. Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse…”
Serafini, K., LaPaglia, D. M., & Steinfeld, M. (2013) · Substance Abuse Research and Treatment · doi:10.4137/sart.s12423
Peter Riederer “70th birthday” Neurobiological foundations of modern addiction treatment
Jacob, C. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0886-8
Sucht, psychiatrische Komorbidität und das serotonerge System
Havemann‐Reinecke, U., & Wedekind, D. (2009) · Nervenheilkunde · doi:10.1055/s-0038-1628677
“Conway (8) konnte einen hochsignifikanten Zusammenhang zwischen Substanzmissbrauch und Abhängigkeit und dem Vorliegen einer zusätzlichen Angst- oder affektiven Störung erkennen.”
BackgroundWohlert, B. (2014) · UA Campus Repository (The University of Arizona) · Cited by 3
Alejandra, P., Martínez, S., Treviño, L. J., Mesa, D., García‐Portilla, M. P., González, P. M., Al‐Halabí, S., Szerman, N., Bobes, J., & Ruiz, P. (2014)
Affective Processing in Acute Alcohol Intoxication
Balodis, I. M. (2008) · QSpace (Queen's University Library)
Prevalence of Depression in Duty Personnel at (A) City Police Headquarters in 2012
Salehi, A., Ataee, T., Asadi, S., Hasanpoor, E., & Heydari, L. (2015) · Cited by 1
1-Year-Old Children Fathers' Depression Related to Positive and Negative Parenting Behaviors With
Davis, R. N., Davis, M. M., Freed, G. L., & Clark, S. J. (2011)
Coêlho, B. M., Andrade, L. H., Guarniero, F. B., & Wang, Y. (2010) · DOAJ (DOAJ: Directory of Open Access Journals) · doi:10.1590/s1516-44462010000400013
Simning, A. (2011) · UR Research (University of Rochester)
Influence of social factors on mothers in treatment for substance use disorders
Hilton, N. V. (2009) · Rutgers University Community Repository (Rutgers University) · doi:10.7282/t3p84c21
Torres, Y., Villa, J. P., Silva, J. B., & Fernández, D. Y. B. (2010)
Adams, C. E., Houle, T. T., Parker, J. D., & Burke, R. S. (2012) · Addictive Disorders & Their Treatment · doi:10.1097/adt.0b013e31824709bb · Cited by 1
The Intersection of Symptomatology in Adult ADHD and Bipolar Disorder
Soleimani, L., Burdick, K. E., Goldberg, J. F., & Simon, A. B. (2013) · Psychiatric Annals · doi:10.3928/00485713-20130109-05
Blazer, D. G., & Hybels, C. F. (2008)
Assessing and Treating Co-occurring Mental Illness
Jones, M. M., & Fireman, M. (2016) · Springer eBooks · doi:10.1007/978-3-319-29863-4_16
Management of Chronic Mental Illnesses and Substance Use Disorders
Sinha, P., Garg, A., Khanna, P., & Khanna, A. (2016) · Advances in psychology, mental health, and behavioral studies (APMHBS) book series · doi:10.4018/978-1-5225-0519-8.ch006
Because it works: A journey through a recovery school
Cleere, P. (2015) · ThinkTech (Texas Tech University)
Capstone: Women, Addiction, and Gender- Sensitive Treatment: A Review of the Literature
Rabideau, R. L. (2016) · Digital Commons-DePaul (DePaul University) · Cited by 1
Ungdom og alkohol - normalutvikling og senere problemer
Skogen, J. C., Brunborg, G. S., & Knudsen, A. K. (2016) · Tidsskrift for psykisk helsearbeid · doi:10.18261/issn.1504-3010-2016-01-02-08 · Cited by 2
Health service utilization among demented individuals with or without mood disorders in Canada
Ackerman, M. (2015) · e-scholar@UOIT (University of Ontario Institute of Technology)
Development of an MMPI-2 Scale to Aid in Assessing Opioid Use Disorder
Chamberlain, J. (2014) · OhioLink ETD Center (Ohio Library and Information Network)
Deep Brain Stimulation Suppresses Gamma Oscillations in Treatment Resistant Depression
Sun, Y. (2012) · TSpace (University of Toronto)
Addictions et troubles des conduites
Gorwood, P. A. P. M. (2017) · doi:10.1016/b978-2-294-74927-8.00018-8
Addictions à l'héroïne, à la cocaïne, au cannabis et autres substances illicites
Blaise, M., Grégoire, M., & Valleur, M. (2017) · EMC - Psychiatrie · doi:10.1016/s0246-1072(17)69632-9
Hazardous Substance Use among People with Psychiatric Disabilities Visiting Day Centers
Eklund, M., & Öjehagen, A. (2018) · Journal of Alcoholism and Drug Dependence · doi:10.4172/2329-6488.1000305
“It is also well-known that people who suffer from psychiatric illness have a more than doubled lifetime risk of acquiring an alcohol or drug use disorder [5-7].”
Background[Gigantiform cementoma (case report)].
Punwutikorn, J. (1982) · PubMed
Cannabis Use Disorders and Related Emergencies
Sidelnik, S. A., & Benzer, T. I. (2019) · Current clinical psychiatry · doi:10.1007/978-3-319-23961-3_4
Mohammadi, R. S., gholamrezaie, S., & Ghadampour, E. (2019) · The Neuroscience Journal of Shefaye Khatam · doi:10.29252/shefa.8.1.31
Expressive Arts in Play Therapy Supervision for Substance Abuse Issues
Sheely‐Moore, A. I., & Daniel, A. (2020) · Advances in psychology, mental health, and behavioral studies (APMHBS) book series · doi:10.4018/978-1-7998-4628-4.ch003
Mental health and alcohol use disorder (AUD) comorbidity
Singh, A. K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819680-9.00003-2 · Cited by 1
Sun, Y. (2017) · TSpace (University of Toronto)
Withdrawal Emergent Recurrent Manic Episodes with Use of “Bhukki”: A Case Report
Nandan, N. K., Singh, L. K., Tikka, S. K., & Shukla, A. (2020) · Indian Journal of Psychological Medicine · doi:10.1177/0253717620960599
Social anxiety and problematic alcohol use among college students: a longitudinal study.
Jørstad‐Stein, E. C. (2014) · TUScholarShare (Temple University) · Cited by 1
Psychiatric Disorders, Personality, and Developmental Factors
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515.009
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515.015
Use Disorders of Cocaine and Methamphetamine
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515.014
Tranquilizers and Sedative Use Disorders
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515.016
Alcohol and Substance Abuse in African Americans
Lawson, W. B., Lawson, R. G., Herrera, J., Sharma, B., & Broadway, A. (2010) · Springer eBooks · doi:10.1007/978-1-4419-0338-9_67
Comorbid Anxiety and Substance Use Disorders
Brady, K. T. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3375-0_20
Problematisk opioidanvändning: om opioidrelaterade dödsfall och LARO i södra Sverige
Andersson, L. (2021) · doi:10.24834/isbn.9789178772124 · Cited by 15
Ward, H., Moggach, L., Tregeagle, S., & Trivedi, H. (2021) · Springer eBooks · doi:10.1007/978-3-030-76429-6_8
Brady, K. T., & Back, S. E. (2021) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615373970.kb45
Frohlich, J. R., Rapinda, K. K., Schaub, M. P., Wenger, A., Baumgartner, C., Johnson, E. A., O’Connor, R. M., Vincent, N., Blankers, M., Ebert, D. D., et al. (2018) · doi:10.2196/preprints.11298
Epidemiology of Psychiatric Illness
Hybels, C. F., & Blazer, D. G. (2016) · Springer eBooks · doi:10.1007/978-1-4939-2528-5_32
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515.018
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515.001
The Biopsychosocial Perspective and Research Methods for Investigation of Substance Use Disorders
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515.002
Sedgewick, A. E., Connery, H. S., & Greenfield, S. F. (2020) · Springer eBooks · doi:10.1007/978-3-030-44459-4_13
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515.010
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515.004
Genetic Influence on Substance Use Disorders
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515.007
Brain Function and Substance Use Disorders
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515.006
Tobacco Use and Nicotine Addiction
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515.012
Behavioral, Cognitive, and Social Factors Promoting SUD
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515.008
Psychopharmacology: Drug Effects on Brain Function
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515.005
Diagnosis of Substance Use Disorders
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515.003
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515.011
Treatment of Substance Use Disorders
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515.017
The Application of Data Science Techniques and Algorithms in Women’s Health StudiesPreprint
Akpan, I. J., & Aguolu, O. G. (2022) · medRxiv · doi:10.1101/2022.03.27.22273006 · Cited by 2
Martino, G. D. (2022) · Springer eBooks · doi:10.1007/978-3-030-67928-6_19-1
Bibliography Panic and Social Anxiety Disorder
(2008) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.6.4.foc459
Management of Chronic Mental Illnesses and Substance Use Disorders
Sinha, P., Garg, A., Khanna, P., & Khanna, A. (2018) · IGI Global eBooks · doi:10.4018/978-1-5225-7666-2.ch001
(2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802852-0.16001-3
Management of Chronic Mental Illnesses and Substance Use Disorders
Sinha, P., Garg, A., Khanna, P., & Khanna, A. (2018) · IGI Global eBooks · doi:10.4018/978-1-5225-7122-3.ch024
Hammani, Z., Taoufik, T., Youssef, O., Soufyane, K., Karrouri, R., & Othemane, Y. (2022) · Indian Journal Of Applied Research · doi:10.36106/ijar/4916315
(2016) · Wiley eBooks · doi:10.1002/9781394259472.refs
Substance‐Related and Addictive Disorders: Drugs
Daughters, S. B., & Yi, J. Y. (2018) · Wiley eBooks · doi:10.1002/9781394258970.ch19
Barbosa-Méndez, S., & Salazar‐Juárez, A. (2024) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-024-01247-7
“…adverse emotional and physical states that occur during cocaine withdrawal are the main factors that precipitate relapse, increase chronic cocaine abuse, and increase cocaine craving (Araos et al., 2014; Conway et al., 2006; D´Souza and Markou, 2010; Grant et al., 2004; Pedraz et al., 2015a, b).”
West, A. L., Correll, L., & Kirschner, J. H. (2024) · Arts & Health · doi:10.1080/17533015.2024.2321944
“Women with SUDs experience high rates of mood and anxiety disorders (Conway et al., 2006), and those in residential treatment often smoke as a strategy to reduce stress and cope with negative emotions (Fallin et al., 2016; Fallin-Bennett et al., 2018; Hackshaw et al., 2011; Martinez Leal et al.,…”
Bustamante, S. A., Gómez, V. L., González, S. M., Restrepo, M. S., Góngora, V. S., Duque, I. T., Vásquez, D., Hincapié, G. M. S., & Restrepo, D. (2024) · Revista Colombiana de Psiquiatría · doi:10.1016/j.rcp.2024.03.003
Heroin and its Effects on the Brain
Krishnan, J. (2024) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815223828124010003
Kerr-Little, A., Bramness, J. G., Newberry, R. C., & Biong, S. N. (2024) · Research Square · doi:10.21203/rs.3.rs-4247627/v1
Singha, R. (2024) · Advances in early childhood and K-12 education · doi:10.4018/979-8-3693-1451-7.ch016
Friend, M. M., Nicodemus, M. C., Cavinder, C., Lemley, C. O., Prince, P., Cagle-Holtcamp, K. A., & Swanson, R. M. (2024) · People and Animals The International Journal of Research and Practice · doi:10.62845/pk9qrmt
Chandra, P. S., Varghese, M., & Supraja, T. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-99967-0.00345-8
Borrelli, E. P., Saad, P., Barnes, N. E., Nelkin, H. D., Dumitru, D., & Lucaci, J. D. (2024) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s484831
Obsessive-compulsive disorder, major depressive disorder, and addiction: the vicious relationship
El-Mallakh, R. S., Shams, J., Doroodgar, M., & Doroodgar, M. (2024) · European Journal of Translational Myology · doi:10.4081/ejtm.2024.13108
Chalmé, R. L., Rubin, E., Evans, S. M., Haney, M., & Foltin, R. W. (2024) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2024.173918 · Cited by 1
Modeling Marijuana Use Willingness and Problems as a Function of Social Rejection and Social Anxiety
Cloutier, R. M. (2019) · University of North Texas Digital Library (University of North Texas) · doi:10.12794/metadc1505189
Caldwell, E., Obiozor, C., Kofos, M. N., Martell, J. P., Agerwala, S. M., & Petrakis, I. L. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-95702-1.00275-x
Executive Deficits in Subjects with Cocaine Use Disorder and High Schooling: A Multiple Case Study
Correa, G. G., Viapiana, V. F., & Rodrigues, A. C. R. D. B. G. (2025) · Springer eBooks · doi:10.1007/978-3-031-82614-6_26
Valenti, O., Rekawek, K. A., Wieser, S., Bulut, H., Scholze, P., & Boehm, S. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1534101 · Cited by 2
Yang, X., Huang, Y., Liu, W., Wu, T., Liu, Z., Gao, S., Zheng, Q., Meng, S., Zheng, J.-W., Lu, L., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5225732
Kerr-Little, A., Bramness, J. G., Newberry, R. C., & Biong, S. N. (2025) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/s13011-025-00653-x · Cited by 1
“SUD commonly co-occurs with psychiatric disorders including depression, anxiety disorders, bipolar disorder, antisocial personality disorder and post-traumatic stress disorder (PTSD) (Conway et al. 2006; Magidson et al. 2012; Reynolds et al. 2005; Torrens et al. 2011).”
Lutz, P.-É., Lalanne, L., Caparros-Roissard, A., Waeckerle, G., Scherer, C., Lebreton, M., Audran, M., Merah, I., Chappuy, M., Avril, E., et al. (2025) · Psychotropes · doi:10.3917/psyt.312.0097
Caton, N., Lysyshyn, M., Cowan, N., & Wood, E. (2025) · Tobacco Control · doi:10.1136/tc-2024-059134
Is Topiramate Helpful in the Management of Cocaine Use-Related Psychiatric Comorbidities?
Patil, T. A., Espiridion, E. D., & Napalinga, K. M. (2025) · Cureus · doi:10.7759/cureus.87935 · Cited by 1
Williams, J., Bretteville‐Jensen, A. L., & Rose, C. D. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5342049
Nestvold, H. H., Haarr, E., Hamina, A., Hjellvik, V., Skurtveit, S. O., & Odsbu, I. (2025) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.70212 · Cited by 1
“International studies commonly cite previous mental health disorders as risk factors for SUDs [6–8], with one Norwegian study reporting that as many as 90% of people with SUD had a lifetime comorbid mental disorder [9].”
Chung, A. K. K., Leung, W., & Tse, C. Y. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1622306
Goldblum, R. S., O’Bryan, E. M., Bimstein, J. G., & McLeish, A. C. (2025) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000001850
García-Torres, M. I., Allen‐Leigh, B., Basto-Abreu, A. C., Escamilla-Núñez, C., Ayala-García, J. C., Cupul‐Uicab, L. A., & Cadena, L. H. (2025) · Journal of Interpersonal Violence · doi:10.1177/08862605251365659 · Cited by 1
“Additionally, more than one-third of individuals with alcohol abuse and 40% to 60% of those abusing other drugs have a mental illness (Calarco & Lobo, 2020; Conway et al., 2006).”
Predicting Substance Addiction in University Students: A DSM-5-Guided Machine Learning Model
Bustamante, P. V., & Ponce-Espinosa, H. (2025) · Lecture notes in computer science · doi:10.1007/978-3-032-09037-9_2
Sandelich, S., Buresh, C. T., Axson, S. A., Linn, B. K., & Mareboina, M. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.120808 · Cited by 2
Metadata
- Authors
- Conway, K. P., Compton, W., Stinson, F. S., & Grant, B. F.
- Affiliations
- National Institutes of Health (US)
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2006-02-15
- Volume
- 67
- Issue
- 02
- Pages
- 247-258
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2059057223
- Cited by
- 934
- References
- 24
- Citations by year
- 2026: 25 · 2025: 42 · 2024: 44 · 2023: 35 · 2022: 56 · 2021: 56 · 2020: 83 · 2019: 38 · 2018: 51 · 2017: 55 · 2016: 53 · 2015: 63 · 2014: 55 · 2013: 56 · 2012: 45
- FWCI
- 24.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- psychiatric comorbidity, mood disorders, anxiety disorders, drug use disorders, substance dependence, substance abuse, lifetime prevalence, sex differences, DSM-IV, illicit drug use
- MeSH terms
- Adolescent, Adult, Alcoholism, Anxiety Disorders, Depressive Disorder, Female, Health Surveys, Humans, Male, Psychiatric Status Rating Scales, Regression Analysis, Sex Factors, United States, Comorbidity, Prevalence, Diagnosis, Dual (Psychiatry), Mood Disorders, Substance-Related Disorders, Diagnostic and Statistical Manual of Mental Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.